Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Novartis jettisons ph. 1 cancer candidate after 0% efficacy
Novartis previously shared an early data cut showing that none of the patients treated with the protein achieved an objective response.
Darren Incorvaia
Feb 19, 2026 2:45pm
Trump met with Makary before FDA’s Moderna walkback: report
Feb 19, 2026 11:30am
J&J halts enrollment in trial of AC Immune Alzheimer's drug
Feb 19, 2026 9:50am
Sanofi backs Altesa's $75M series B to bankroll rhinovirus study
Feb 19, 2026 7:00am
Fierce Biotech Fundraising Tracker '26: Altesa; Korsana & more
Feb 19, 2026 10:30am
Fierce Healthcare
NIH Director Jay Bhattacharya to take over as temporary CDC head
Feb 18, 2026 4:30pm
More News
GSK inks 5-year deal with Jackson Lab for neuro research
Feb 18, 2026 3:30pm
Blood from pediatricians yields new antiviral antibodies
Feb 18, 2026 2:15pm
Fierce Pharma
Sen. Cassidy offers proposals to reshape FDA
Feb 18, 2026 11:45am
Rasayana Tx ingests GI candidate in $36M deal
Feb 18, 2026 10:40am
See more stories